<DOC>
	<DOCNO>NCT00189566</DOCNO>
	<brief_summary>This study look efficacy safety weekly administration paclitaxel ( Taxol® ) monotherapy compare paclitaxel combination topotecan carboplatin patient ovarian cancer early relapse .</brief_summary>
	<brief_title>Taxol® Monotherapy Combination With Topotecan Carboplatin Patients With Epithelial Ovarian Cancer Early Relapse</brief_title>
	<detailed_description>The main purpose research study find treatment early relapse ovarian fallopian tube peritoneal cancer paclitaxel ( Taxol* ) weekly administer , low dos combination topotecan ( Hycamtin* ) carboplatin improve efficacy compare weekly administration paclitaxel monotherapy . Tolerance three group compare .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Patients age &gt; 18 Histologically proven diagnosis cancer ovary , fallopian tube peritoneum Peritoneal and/or node and/or visceral metastasis Disease progression treatment within 6 month first second platinumbased line A period 3 week last chemotherapy inclusion Measurable disease ( Response Evaluation Criteria Solid Tumors [ RECIST ] criterion ) cancer antigen ( CA ) 125 assessable disease ( Gynecologic Cancer Intergroup [ GCIG ] criterion ) ECOG performance status &lt; 2 Life expectancy least 12 week Previously receive weekly administration paclitaxel chemotherapy Involved trial within last 30 day Previously receive bone marrow autogreffe irradiation abdomen within 5 year , due intensive chemotherapy Prior diagnosis malignancy History ischemic cardiopathy , congestive heart failure ( New York Heart Association [ NYHA ] &gt; 2 ) , arrhythmia , hypertension , significant valvulopathy Preexisting motor sensory neurologic pathology symptom National Cancer Institute ( NCI ) Common Terminology Criteria Adverse Events ( CTCAE ) grade &gt; 2 Bone marrow , renal , hepatic insufficiency Severe active infection occlusive subocclusive disease History symptomatic brain metastasis Fertile woman use adequate contraceptive method Pregnant breast feed woman Hypersensitivity compound chemically related paclitaxel , topotecan , carboplatin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Relapse within 6 month</keyword>
	<keyword>Previously receive taxane derivative</keyword>
</DOC>